Category

Blastoma

This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice Blastoma

This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice

Researchers at Oregon State University have developed a promising experimental strategy for treating glioblastoma, the most aggressive form of brain cancer. Fewer than 30% of patients survive for two years after diagnosis. The work, led by Oleh Taratula, Olena Taratula and Yoon Tae Goo of the OSU College of Pharmacy,…
bubmag
July 17, 2026
‘Antiques Roadshow’ star Theo Burrell dead at 39 after four-year battle with brain cancer Blastoma

‘Antiques Roadshow’ star Theo Burrell dead at 39 after four-year battle with brain cancer

“Antiques Roadshow” star Theo Burrell has died at age 39 following a four-year battle with brain cancer. Burrell’s family announced the tragic news in a statement shared on the reality star’s Instagram Sunday. “It is with great sadness that I share the news that Theo passed away peacefully surrounded by…
bubmag
July 15, 2026
Editor’s pick: Trogenix Blastoma

Editor’s pick: Trogenix

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating ‘synthetic super-enhancers’ that could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma. Author information Authors and Affiliations Philadelphia, PA, USA Michael Eisenstein Authors Michael…
bubmag
June 30, 2026
mRNA Vaccine Shrinks Deadly Childhood Cancer Tumors by 70% Blastoma

mRNA Vaccine Shrinks Deadly Childhood Cancer Tumors by 70%

A new preclinical study suggests an experimental mRNA vaccine could help the immune system fight neuroblastoma, one of the deadliest childhood cancers. Credit: Stock An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models. The success of mRNA vaccines during the COVID-19 pandemic sparked interest…
bubmag
June 29, 2026
TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control Blastoma

TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control

Proceedings of the National Academy of Sciences, Volume 123, Issue 25, June 2026. SignificanceICAM-1/LFA-1 interactions enhance immune cell avidity, stabilizing immune synapses and improving cytotoxicity in solid tumors. The IFNγ signaling pathway was found to be essential for ICAM1 upregulation. Here, we revealed in glioblastoma that ...Read More
bubmag
June 18, 2026
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026 Blastoma

Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Published : , ,   Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea, June 15, 2026 /PRNewswire/ --…
bubmag
June 15, 2026